Chai builds the design suite for molecules. We train frontier models that learn the underlying foundations of biochemical structure and interaction, so scientists can move faster and pursue targets that other methods cannot reach.
AI is reinventing life sciences the same way it reinvented software engineering, and Chai is at the forefront of this shift. Leading pharmaceutical companies like Eli Lilly, Pfizer, and Novartis are adopting our platform to power their drug discovery programs.
We value diverse perspectives and are ready to find greatness in unexpected places.
We are building out our partnerships founding team and looking to make a few key hires to anchor the effort. You will help set the terms and drive deal execution with the world's leading life sciences companies, establishing relationships that will shape our future.
These are complex transactions with sophisticated partners. You'll need to lean into the many details that make these partnerships work, while creating urgency and alignment around a common vision.
This is a critical role at a pivotal time for the business: Deal volume and demand are accelerating fast. It will be a lot of fun, a lot of work, and extraordinarily rewarding.
We index on outlier performance and relentless execution. You sweat the small stuff, you think big, you always take ownership, and you strive for win-win outcomes. We can count on you.
We value biopharma domain experience and deal-making savvy, and we are also more than willing to make a bet on rising talent. Low-ego, high-EQ, motivated and mission-driven is what we're looking for.
The opportunity to work at the vanguard of AI research and frontier biology, with world-class people, on a mission that matters. We protect & promote a culture of high velocity and ownership. We compensate our team accordingly.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
Chai builds the design suite for molecules by training frontier models that learn the foundations of biochemical structure and interaction. They are at the forefront of AI's reinvention of life sciences.